Antibody responses to Cryptococcus neoformansin Indian patients with cryptococcosis

Medical Mycology

Volumn 46, Issue 5, 2008, Pages 457-463

  Champa Saha, Dolan ^a   Xess, Immaculata ^a   Yong Zeng, Wang ^b   Goldman, David L ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

AIDS; Cryptococcosis; Cryptococcus neoformans; Serology

Indexed keywords

CYTOPLASM PROTEIN; FUNGAL PROTEIN; FUNGUS ANTIBODY; GLUCURONOXYLOMANNAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MANNOPROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNGAL STRAIN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOBLOTTING; INDIAN; KIDNEY TRANSPLANTATION; LUPUS VULGARIS; MALE; MENINGITIS; MYCOBACTERIUM TUBERCULOSIS; SARCOIDOSIS; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, FUNGAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOBLOTTING; INDIA; MALE; MIDDLE AGED; POLYSACCHARIDES;

FILOBASIDIELLA NEOFORMANS;

EID: 48249116733     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780801961345     Document Type: Article

References (28)

1. Casadevall, A. and Pirofski, L. (2005) Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformans. 5, pp. 421-433.
2. Zebedee, SL, Koduri, RK Mukherjee, J. et al. (1994) Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans. 38, pp. 1507-1514.
3. Feldmesser, M. and Casadevall, A. (1997) Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection. 158, pp. 790-799.
4. Chen, LC, Goldman, DL Doering, TL et al. (1999) Antibody response to Cryptococcus neoformans proteins in rodents and humans. 67, pp. 2218-2224.
5. Neuville, S., Lortholary, O. and Dromer, F. (2000) Do kinetics of the humoral response to Cryptococcus neoformans proteins during murine cryptococcosis reflect outcome?. 68, pp. 3724-3726.
6. Parra, C., Gonzalez, JM, Castaneda, E. and Fiorentino, S. (2005) Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice. 25, pp. 110-119.
7. Vogel, RA. (1966) The indirect fluorescent antibody test for the detection of antibody in human cryptococcal disease. 116, pp. 573-580.
8. Diamond, RD and Bennett, JE. (1974) Prognostic factors in cryptococcal meningitis. A study in 111 cases. 80, pp. 176-181.
9. Hamilton, AJ, Figueroa, JI, Jeavons, L. and Seaton, RA. (1997) Recognition of cytoplasmic yeast antigens of Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. gattii by immune human sera. 17, pp. 111-119.
10. Banerjee, U., Datta, K., Majumdar, T. and Gupta, K. (2001) Cryptococcosis in India: The awakening of a giant?. 39, pp. 51-67.
11. Prasad, KN, Agarwal, J. Nag, VL et al. (2003) Cryptococcal infection in patients with clinically diagnosed meningitis in a tertiary care center. 51, pp. 364-366.
12. Goldman, DL, Khine, H. Abadi, J. et al. (2001) Serologic evidence for Cryptococcus neoformans infection in early childhood. 107, p. E66.
13. Biondo, C., Messina, L. Bombaci, M. et al. (2005) Characterization of two novel cryptococcal mannoproteins recognized by immune sera. 73, pp. 7348-7355.
14. Casadevall, A., Mukherjee, J. and Scharff, MD. (1992) Monoclonal antibody based ELISAs for cryptococcal polysaccharide. 154, pp. 27-35.
15. Cherniak, R., Morris, LC, Anderson, BC and Meyer, SA. (1991) Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans. 59, pp. 59-64.
16. Pitzurra, L., Perito, S. Baldelli, F. et al. (2003) Humoral response against Cryptococcus neoformans mannoprotein antigens in HIV-infected patients. 133, pp. 91-96.
17. Kakeya, H., Udono, H. Maesaki, S. et al. (1999) Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis. 115, pp. 485-490.
18. Perfect, JR and Casadevall, A. (1998) Human Cryptococcosis. pp. 407-457. ASM Press, Washington, DC
19. Lee, SC, Dickson, DW and Casadevall, A. (1996) Pathology of cryptococcal meningoencephalitis: Analysis of 27 patients with pathogenetic implications. 27, pp. 839-847.
20. Lee, SC and Casadevall, A. (1996) Polysaccharide antigen in brain tissue of AIDS patients with cryptococcal meningitis. 23, pp. 194-195.
21. Dromer, F., Aucouturier, P. Clauvel, JP et al. (1988) Cryptococcus neoformans antibody levels in patients with AIDS. 20, pp. 283-285.
22. Houpt, DC, Pfrommer, GS Young, BJ et al. (1994) Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan. 62, pp. 2857-2864.
23. DeShaw, M. and Pirofski, LA. (1995) Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals. 99, pp. 425-432.
24. Kimball, HR, Hasenclever, HF and Wolff, SM. (1967) Detection of circulating antibody in human cryptococcosis by means of a bentonite flocculation technique. 95, pp. 631-637.
25. Dromer, F. and Charreire, J. (1991) Improved amphotericin B activity by a monoclonal anti-Cryptococcus neoformans antibody: Study during murine cryptococcosis and mechanisms of action. 163, pp. 1114-1120.
26. Mukherjee, S., Lee, S. Mukherjee, J. et al. (1994) Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. 62, pp. 1079-1088.
27. Fleuridor, R., Lyles, RH and Pirofski, L. (1999) Quantitative and qualitative differences in the serum antibody profiles of human immunodeficiency virus-infected persons with and without Cryptococcus neoformans meningitis. 180, pp. 1526-1535.
28. Jalali, Z., Ng, L., Singh, N. and Pirofski, LA. (2006) Antibody response to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan in patients after solid-organ transplantation. 13, pp. 740-746.